Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies

David W. Nyman, Kimberley J. Campbell, Evan Hersh, Kristen Long, Kelly Richardson, Vuong Trieu, Neil Desai, Michael J. Hawkins, Daniel D. Von Hoff

Research output: Contribution to journalArticlepeer-review

231 Scopus citations

Fingerprint Dive into the research topics of 'Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences